In patients with hepatitis, why is there an increased risk of drug toxicity?

Study for the Medical FIDSAP v2 Test. Sharpen your skills with flashcards and multiple-choice questions, complete with hints and explanations. Prepare effectively for your upcoming test!

Multiple Choice

In patients with hepatitis, why is there an increased risk of drug toxicity?

Increased drug toxicity in hepatitis comes from reduced hepatic detoxification and metabolism. The liver is the primary organ that metabolizes and detoxifies drugs through enzymatic processes, transforming lipophilic compounds into more water-soluble forms for elimination. When hepatitis damages hepatocytes, these detoxification pathways are impaired, so drugs linger longer in the bloodstream and their levels can rise, increasing the chance of toxic effects even at standard doses. Filtration is mainly a kidney function and not the central mechanism for drug detoxification, so the other statements don’t explain why toxicity risk rises with liver disease.

Increased drug toxicity in hepatitis comes from reduced hepatic detoxification and metabolism. The liver is the primary organ that metabolizes and detoxifies drugs through enzymatic processes, transforming lipophilic compounds into more water-soluble forms for elimination. When hepatitis damages hepatocytes, these detoxification pathways are impaired, so drugs linger longer in the bloodstream and their levels can rise, increasing the chance of toxic effects even at standard doses.

Filtration is mainly a kidney function and not the central mechanism for drug detoxification, so the other statements don’t explain why toxicity risk rises with liver disease.

More practice questions